April 5, 2018
Weather aside, a sure sign of spring at the Koch Institute is the announcement of the latest cohort of research teams supported by the Bridge Project, the Koch Institute’s collaborative partnership with Dana-Farber/Harvard Cancer Center. This year, nine new projects seek improved understandings and test novel approaches, from exploring a new target for brain cancer treatment, to understanding how obesity may help colon cancer evade the immune system, to developing personalized therapeutic vaccines for metastatic cancers. Also included is a foray into a new disease area, ileal carcinoids. This neuroendocrine cancer is hard to treat and to study, partly due to a lack of reliable models. Combining advances in modeling, drug delivery, and highly sensitive analysis, the team aims to better understand and predict the tumors’ therapeutic response. See the 2018 Bridge Projects.